Long-Term Care Resident Awareness and Interest in Spasticity Treatments
Spasticity is common in long-term care settings (affecting up to one in three residents), yet it remains under-treated despite safe and effective, Food and Drug Administration (FDA)-approved therapies. One barrier to treatment may be lack of awareness of available therapies for long-term care reside...
Main Authors: | Mallory L. Hacker, Michael S. Putman, Chandler E. Gill, Maxim Turchan, Taylor S. Hudson, Amanda D. Currie, Fenna T. Phibbs, David Charles |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Geriatrics |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3417/6/1/21 |
Similar Items
-
Spasticity: A review of Methods for Assessment and Treatment
by: Mohammad Amouzadeh Khalili, et al.
Published: (2011-10-01) -
Spasticity : diagnosis and management /
by: Brashear, Allison, et al.
Published: (c201) -
Recent State of Wearable IMU Sensors Use in People Living with Spasticity: A Systematic Review
by: Yehuda Weizman, et al.
Published: (2022-02-01) -
Technology-assisted assessment of spasticity: a systematic review
by: Xinliang Guo, et al.
Published: (2022-12-01) -
The therapeutic effects of physical treatment for patients with hereditary spastic paraplegia: a narrative review
by: Armando Di Ludovico, et al.
Published: (2023-11-01)